 | • レポートコード：MRC2-11QY10931 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自己免疫治療薬のグローバル市場について調査・分析したレポートです。種類別（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE））市場規模、用途別（病院、在宅医療、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自己免疫治療薬の競争状況、市場シェア ・世界の自己免疫治療薬市場：種類別市場規模 2015年-2020年（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE）） ・世界の自己免疫治療薬市場：種類別市場規模予測 2021年-2026年（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE）） ・世界の自己免疫治療薬市場：用途別市場規模 2015年-2020年（病院、在宅医療、専門クリニック） ・世界の自己免疫治療薬市場：用途別市場規模予測 2021年-2026年（病院、在宅医療、専門クリニック） ・北米の自己免疫治療薬市場分析：米国、カナダ ・ヨーロッパの自己免疫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自己免疫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自己免疫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自己免疫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、GSK、AbbVie、Johnson & Johnson、Biogen、Amgen、Pfizer、Roche、Baxter ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.
Market Analysis and Insights: Global Autoimmune Drugs Market
The global Autoimmune Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Autoimmune Drugs Scope and Market Size
Autoimmune Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
GSK
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
Roche
Baxter
Market segment by Type, the product can be split into
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Market segment by Application, split into
Hospitals
Homecare Settings
Specialty Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Drugs Revenue
1.4 Market by Type
1.4.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rheumatoid Arthritis (RA)
1.4.3 Multiple Sclerosis (MS)
1.4.4 Psoriasis
1.4.5 Inflammatory Bowel Disease (IBD)
1.4.6 Ankylosing Spondylitis (AS)
1.4.7 Systemic Lupus Erythematosus (SLE)
1.5 Market by Application
1.5.1 Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Homecare Settings
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Perspective (2015-2026)
2.2 Global Autoimmune Drugs Growth Trends by Regions
2.2.1 Autoimmune Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autoimmune Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Autoimmune Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Drugs Players by Market Size
3.1.1 Global Top Autoimmune Drugs Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Drugs Market Concentration Ratio
3.2.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2019
3.3 Autoimmune Drugs Key Players Head office and Area Served
3.4 Key Players Autoimmune Drugs Product Solution and Service
3.5 Date of Enter into Autoimmune Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Autoimmune Drugs Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Autoimmune Drugs Market Size by Application (2015-2020)
5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autoimmune Drugs Market Size (2015-2020)
6.2 Autoimmune Drugs Key Players in North America (2019-2020)
6.3 North America Autoimmune Drugs Market Size by Type (2015-2020)
6.4 North America Autoimmune Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autoimmune Drugs Market Size (2015-2020)
7.2 Autoimmune Drugs Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Drugs Market Size by Type (2015-2020)
7.4 Europe Autoimmune Drugs Market Size by Application (2015-2020)
8 China
8.1 China Autoimmune Drugs Market Size (2015-2020)
8.2 Autoimmune Drugs Key Players in China (2019-2020)
8.3 China Autoimmune Drugs Market Size by Type (2015-2020)
8.4 China Autoimmune Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autoimmune Drugs Market Size (2015-2020)
9.2 Autoimmune Drugs Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Drugs Market Size by Type (2015-2020)
9.4 Japan Autoimmune Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Autoimmune Drugs Market Size (2015-2020)
10.2 Autoimmune Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020)
11 India
11.1 India Autoimmune Drugs Market Size (2015-2020)
11.2 Autoimmune Drugs Key Players in India (2019-2020)
11.3 India Autoimmune Drugs Market Size by Type (2015-2020)
11.4 India Autoimmune Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Autoimmune Drugs Market Size (2015-2020)
12.2 Autoimmune Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Drugs Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Autoimmune Drugs Introduction
13.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK Autoimmune Drugs Introduction
13.2.4 GSK Revenue in Autoimmune Drugs Business (2015-2020)
13.2.5 GSK Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Autoimmune Drugs Introduction
13.3.4 AbbVie Revenue in Autoimmune Drugs Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Autoimmune Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Biogen
13.5.1 Biogen Company Details
13.5.2 Biogen Business Overview
13.5.3 Biogen Autoimmune Drugs Introduction
13.5.4 Biogen Revenue in Autoimmune Drugs Business (2015-2020)
13.5.5 Biogen Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Autoimmune Drugs Introduction
13.6.4 Amgen Revenue in Autoimmune Drugs Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Autoimmune Drugs Introduction
13.7.4 Pfizer Revenue in Autoimmune Drugs Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview
13.8.3 Roche Autoimmune Drugs Introduction
13.8.4 Roche Revenue in Autoimmune Drugs Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Baxter
13.9.1 Baxter Company Details
13.9.2 Baxter Business Overview
13.9.3 Baxter Autoimmune Drugs Introduction
13.9.4 Baxter Revenue in Autoimmune Drugs Business (2015-2020)
13.9.5 Baxter Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Autoimmune Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Autoimmune Drugs Revenue
Table 3. Ranking of Global Top Autoimmune Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autoimmune Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rheumatoid Arthritis (RA)
Table 6. Key Players of Multiple Sclerosis (MS)
Table 7. Key Players of Psoriasis
Table 8. Key Players of Inflammatory Bowel Disease (IBD)
Table 9. Key Players of Ankylosing Spondylitis (AS)
Table 10. Key Players of Systemic Lupus Erythematosus (SLE)
Table 11. Global Autoimmune Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Autoimmune Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Autoimmune Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Autoimmune Drugs Market Share by Regions (2015-2020)
Table 15. Global Autoimmune Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Autoimmune Drugs Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Autoimmune Drugs Market Growth Strategy
Table 21. Main Points Interviewed from Key Autoimmune Drugs Players
Table 22. Global Autoimmune Drugs Revenue by Players (2015-2020) (Million US$)
Table 23. Global Autoimmune Drugs Market Share by Players (2015-2020)
Table 24. Global Top Autoimmune Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2019)
Table 25. Global Autoimmune Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Autoimmune Drugs Product Solution and Service
Table 28. Date of Enter into Autoimmune Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 31. Global Autoimmune Drugs Market Size Share by Type (2015-2020)
Table 32. Global Autoimmune Drugs Revenue Market Share by Type (2021-2026)
Table 33. Global Autoimmune Drugs Market Size Share by Application (2015-2020)
Table 34. Global Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 35. Global Autoimmune Drugs Market Size Share by Application (2021-2026)
Table 36. North America Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Autoimmune Drugs Market Share (2019-2020)
Table 38. North America Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 39. North America Autoimmune Drugs Market Share by Type (2015-2020)
Table 40. North America Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. North America Autoimmune Drugs Market Share by Application (2015-2020)
Table 42. Europe Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Autoimmune Drugs Market Share (2019-2020)
Table 44. Europe Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Autoimmune Drugs Market Share by Type (2015-2020)
Table 46. Europe Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Autoimmune Drugs Market Share by Application (2015-2020)
Table 48. China Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 49. China Key Players Autoimmune Drugs Market Share (2019-2020)
Table 50. China Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. China Autoimmune Drugs Market Share by Type (2015-2020)
Table 52. China Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. China Autoimmune Drugs Market Share by Application (2015-2020)
Table 54. Japan Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Autoimmune Drugs Market Share (2019-2020)
Table 56. Japan Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Autoimmune Drugs Market Share by Type (2015-2020)
Table 58. Japan Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Autoimmune Drugs Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Autoimmune Drugs Market Share (2019-2020)
Table 62. Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Autoimmune Drugs Market Share by Type (2015-2020)
Table 64. Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Autoimmune Drugs Market Share by Application (2015-2020)
Table 66. India Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 67. India Key Players Autoimmune Drugs Market Share (2019-2020)
Table 68. India Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. India Autoimmune Drugs Market Share by Type (2015-2020)
Table 70. India Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. India Autoimmune Drugs Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Autoimmune Drugs Market Share (2019-2020)
Table 74. Central & South America Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Autoimmune Drugs Market Share by Type (2015-2020)
Table 76. Central & South America Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Autoimmune Drugs Market Share by Application (2015-2020)
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Product
Table 81. Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 82. Eli Lilly Recent Development
Table 83. GSK Company Details
Table 84. GSK Business Overview
Table 85. GSK Product
Table 86. GSK Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 87. GSK Recent Development
Table 88. AbbVie Company Details
Table 89. AbbVie Business Overview
Table 90. AbbVie Product
Table 91. AbbVie Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 92. AbbVie Recent Development
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 97. Johnson & Johnson Recent Development
Table 98. Biogen Company Details
Table 99. Biogen Business Overview
Table 100. Biogen Product
Table 101. Biogen Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 102. Biogen Recent Development
Table 103. Amgen Company Details
Table 104. Amgen Business Overview
Table 105. Amgen Product
Table 106. Amgen Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 107. Amgen Recent Development
Table 108. Pfizer Company Details
Table 109. Pfizer Business Overview
Table 110. Pfizer Product
Table 111. Pfizer Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 112. Pfizer Recent Development
Table 113. Roche Business Overview
Table 114. Roche Product
Table 115. Roche Company Details
Table 116. Roche Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 117. Roche Recent Development
Table 118. Baxter Company Details
Table 119. Baxter Business Overview
Table 120. Baxter Product
Table 121. Baxter Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)
Table 122. Baxter Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Drugs Market Share by Type: 2020 VS 2026
Figure 2. Rheumatoid Arthritis (RA) Features
Figure 3. Multiple Sclerosis (MS) Features
Figure 4. Psoriasis Features
Figure 5. Inflammatory Bowel Disease (IBD) Features
Figure 6. Ankylosing Spondylitis (AS) Features
Figure 7. Systemic Lupus Erythematosus (SLE) Features
Figure 8. Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Homecare Settings Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Autoimmune Drugs Report Years Considered
Figure 13. Global Autoimmune Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Autoimmune Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Autoimmune Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Autoimmune Drugs Market Share by Players in 2019
Figure 18. Global Top Autoimmune Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Drugs Revenue in 2019
Figure 20. North America Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
全身性エリテマトーデス（SLE）治療薬の世界市場（～2026年） SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
- 強直性脊椎炎治療の世界市場（～2026年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…
- 自己免疫・炎症性免疫調節剤の世界市場（～2026年） Market Analysis and Insights: Global Autoimmune and Inflammatory Immunomodulators Market The global Autoimmune and Inflammatory Immunomodulators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autoimmune and Inflammato…
- 自己免疫疾患診断の世界市場（～2026年） The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific. In terms of geography, the Americas led the …